Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Lyko Group in connection with its listing on Nasdaq First North Premier
Mandate

Vinge advises Lyko Group in connection with its listing on Nasdaq First North Premier

December 12, 2017

Vinge has advised Lyko Group AB (publ) (“Lyko”) in connection with its listing on Nasdaq First North Premier.

The prospectus was published on 30 November 2017 and the trading on Nasdaq First North Premier began on 12 December 2017. The total value of the offering amounted to approximately SEK 281 million assuming that the over-allotment option is fully exercised.

Lyko is an omnichannel platform for hair care and beauty. The operations consist of the websites Lyko.se, one of Sweden’s leading destinations for hair care and beauty products online, Lyko.no and wholly owned stores in Sweden and Norway, amounting to 40, of which 39 with associated salons.  

Vinge’s team primarily consisted of partners Jonas Bergström and Dain Hård Nevonen together with associates Joakim Hagberg, Sabina Börjesson and Fredric Reissmüller. Michaela Cronemyr advised on due diligence. Maria Schultzberg and Victor Ericsson advised on tax issues. Albert Wållgren and Lionardo Ojeda advised on financing issues.
 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025